(19)
(11) EP 3 679 068 A2

(12)

(88) Date of publication A3:
11.04.2019

(43) Date of publication:
15.07.2020 Bulletin 2020/29

(21) Application number: 18782834.8

(22) Date of filing: 06.09.2018
(51) International Patent Classification (IPC): 
C07K 16/18(2006.01)
C07K 16/30(2006.01)
 C07K 16/28(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/US2018/049798
(87) International publication number:
WO 2019/051122 (14.03.2019 Gazette 2019/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.09.2017 US 201762555943 P
08.09.2017 US 201762555999 P

(71) Applicant: Maverick Therapeutics, Inc.
Brisbane, CA 94005 (US)

(72) Inventors:
  • DUBRIDGE, Robert, B.
    San Francisco CA 94118 (US)
  • PANCHAL, Anand
    San Francisco CA 94118 (US)

(74) Representative: HGF 
1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)

   


(54) CONDITIONALLY ACTIVATED BINDING MOIETIES CONTAINING Fc REGIONS